PLA2R1 and lipoprotein glomerulopathy: Compared with other glomerulopathy groups, the DN group had a higher prevalence of DR and SBP, while the IMN group had a higher UTP level and anti-PLA2R antibody positive rate, but lower ALB, BUN, Scr, and eGFR (P < 0.05).